Marine Biotechnology Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 8.50 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | Europe |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Marine Biotechnology Market Analysis
The marine biotechnology market is expected to register a CAGR of 8.5% over the forecast period.
The COVID-19 pandemic affected demand and production in the marine biotechnology industry during the initial phase. On the other hand, the pandemic aided the production of marine-derived supplements since they provided potential health benefits against the COVID-19 infection. For instance, as per the article published in the Journal of Antioxidants in February 2022, several marine algae species have been utilized for their bioactive metabolites with potential antiviral and immunomodulatory activities. Thus, the surging use of marine-derived supplements during the pandemic significantly impacted the market growth. However, with the decrease in number of COVID-19 cases, the marine biotechnology market has gained stable growth and is expected to do the same during the forecast period.
The increase in the usage of marine organisms, such as algae and fungi, in different industries, such as pharmaceuticals, cosmetics, food, and agriculture, is a major factor boosting the growth of the marine biotechnology market. For instance, in July 2021, a team of scientists from the National Institute of Ocean Technology, India, developed an anti-ageing ingredient for making cosmetics with the help of deep-sea bacteria. Furthermore, there is an increasing demand for marine-derived nutritional supplements in developed countries such as the United States, Germany, and the United Kingdom. According to an article published in the Journal of Frontiers in Marine Science in February 2022, certain marine microbes which thrive in harsh environmental conditions produce antioxidant, antibacterial, apoptotic, antitumoral, and antiviral chemicals, which could be used in the production of functional food ingredients for health maintenance and chronic disease prevention. The rise in the utilization of marine resources for the production of nutritional supplements is expected to add to the market's growth during the forecast period. Moreover, high dietary levels of polyunsaturated fatty acids are recommended for infants. These healthy fatty acids are produced in large quantities by marine microalgal species. Advancements in the fields of fisheries, drug discovery, and aquaculture and an increase in awareness regarding the untapped potential and use of marine organisms in different industries are expected to increase demand for marine biotechnology sources shortly.
However, the lack of exploration of the oceans and the limited ability to culture marine microorganisms in laboratory conditions will likely restrict the market's growth during the forecast period.
Marine Biotechnology Market Trends
The Medical and Pharmaceutical Segment is Expected to Register the Significant Growth Over the Forecast Period
The medical and pharmaceutical segment is anticipated to hold a significant market share over the analysis period. Currently, microbially derived drugs are increasingly being used in the treatment of infectious diseases and chronic diseases. The most commonly used microbially derived drugs are penicillin, actinomycin, cephalosporins, streptomycin, and cyclosporin.
The increase in research activities related to using marine organisms to produce different therapeutics for various diseases is expected to boost the segment's growth. For instance, in January 2021, scientists at the University of California identified structurally diverse natural compounds in the marine environment. These compounds are expected to help in the development of antiviral therapeutics. Moreover, according to the study published in Biotechnology in Healthcare Journal in March 2022, nearly 11,000 natural effects with nutrition and pharmacological properties have been reported in marine algae. Many compounds found in micro and macroalgae have critical pharmacological properties, such as antibacterial, antifungal, antiviral, antiherpetic, antioxidative, and hypoglycemic properties.
With the advancement in technology, the ability to culture marine organisms has improved. For instance, in April 2021, scientists in Japan successfully cultured the first stable coral cell lines. Such advancement and increased research activities related to using marine organisms in the pharmaceutical industry are expected to open new avenues for producing different biomaterials from marine organisms. This, in turn, can promote the demand for marine biotechnology in the medical and pharmaceutical industries.
Europe is Expected to Hold a Significant Share in the Marine Biotechnology Market Over the Forecast Period
Europe is expected to hold a significant market share throughout the forecast period. The government's support to promote the use of natural marine products and the availability of funding for developing these products will help boost the market growth in Germany during the forecast period. For instance, in March 2021, Bluu Biosciences, a German-based biotech firm, received almost EUR 7 million (USD 7.8 million) to produce high-quality, sustainable fish products from cell cultures.
The presence of sophisticated healthcare infrastructure, technological advancements in marine biotechnology, and the growing demand for marine organisms in the pharmaceutical and cosmetic industries are major factors for the high demand for marine biotechnology in Europe. For instance, in March 2021, Sea4Us planned on developing a remedy for chronic pain, a non-opioid analgesic, with the help of marine bioproducts. The company has worked on many European Commission-supported projects.
Hence, the factors mentioned above and the large marine-farming operations in Europe are expected to boost the market's growth in Europe.
Marine Biotechnology Industry Overview
The marine biotechnology market is moderately competitive and consists of a large number of major players, including BASF SE, AstaReal Co., Ltd., Aker Biomarine, Euglena Co., Ltd., Cyanotech Corporation, and Earthrise Nutritionals LLC, among others.
Marine Biotechnology Market Leaders
-
Cyanotech Corporation
-
Marinomed Biotech AG
-
PharmaMar SA
-
BASF SE
-
AstaReal Co., Ltd.
*Disclaimer: Major Players sorted in no particular order
Marine Biotechnology Market News
- December 2022: TransGen Biotech Co., Ltd. launched Uracil-DNA Glycosylase (Low Temperature), which is a recombinant protein derived from psychrophile marine bacteria for the elimination of aerosol contamination caused by polymerase chain reaction (PCR) products containing deoxyuridine (dU).
- March 2022: GlaxoSmithKline and LifeMine Therapeutics signed a contract for USD 70 million to develop three candidates using LifeMine's fungi-based drug discovery engine.
Marine Biotechnology Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increase in the Usage of Marine Organisms in the Pharmaceutical and Cosmetic Industries
- 4.2.2 Increasing Demand for Marine-Derived Nutritional Supplements
- 4.2.3 Advancements in the Field of Fisheries and Drug Discovery
-
4.3 Market Restraints
- 4.3.1 Lack of Exploration in Oceans
- 4.3.2 Limited Ability to Culture Marine Micro-organisms in Laboratories
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Bargaining Power of Suppliers
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Threat of New Entrants
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
-
5.1 By Source
- 5.1.1 Corals and Sponges
- 5.1.2 Algae
- 5.1.3 Marine Viruses
- 5.1.4 Marine Fungi
- 5.1.5 Other Sources
-
5.2 By End User
- 5.2.1 Medical and Pharmaceutical
- 5.2.2 Food Industry
- 5.2.3 Cosmetics Industry
- 5.2.4 Chemical Industry
- 5.2.5 Other End Users
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle-East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle-East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 BASF SE
- 6.1.2 AstaReal Co., Ltd.
- 6.1.3 Aker Biomarine
- 6.1.4 Euglena Co.,Ltd.
- 6.1.5 Cyanotech Corporation
- 6.1.6 Earthrise Nutritionals LLC
- 6.1.7 CP Kelco U.S., Inc
- 6.1.8 Bluebiotech International GmbH
- 6.1.9 Marinomed Biotech AG
- 6.1.10 PharmaMar SA
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityMarine Biotechnology Industry Segmentation
As per the scope of the report, marine biotechnology is the use of living cells and cell materials to develop products with the help of marine organisms through the application of molecular biology, biotechnology, cell biology, and bioinformatics. The marine biotechnology market is segmented by source (marine fungi, marine algae, corals and sponges, marine viruses, and other sources), end user (medical and pharmaceutical, food industry, cosmetics industry, chemical industry, and other end users), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers the value (in USD) for the above segments.
| By Source | Corals and Sponges | |
| Algae | ||
| Marine Viruses | ||
| Marine Fungi | ||
| Other Sources | ||
| By End User | Medical and Pharmaceutical | |
| Food Industry | ||
| Cosmetics Industry | ||
| Chemical Industry | ||
| Other End Users | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle-East and Africa | GCC |
| South Africa | ||
| Rest of Middle-East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Marine Biotechnology Market Research FAQs
What is the current Global Marine Biotechnology Market size?
The Global Marine Biotechnology Market is projected to register a CAGR of 8.5% during the forecast period (2024-2029)
Who are the key players in Global Marine Biotechnology Market?
Cyanotech Corporation , Marinomed Biotech AG, PharmaMar SA, BASF SE and AstaReal Co., Ltd. are the major companies operating in the Global Marine Biotechnology Market.
Which is the fastest growing region in Global Marine Biotechnology Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Marine Biotechnology Market?
In 2024, the Europe accounts for the largest market share in Global Marine Biotechnology Market.
What years does this Global Marine Biotechnology Market cover?
The report covers the Global Marine Biotechnology Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Marine Biotechnology Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Marine Biotechnology Industry Report
Statistics for the 2024 Marine Biotechnology market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Marine Biotechnology analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
